MDxHealth SA (MDXH)
MDxHealth SA Statistics
Share Statistics
MDxHealth SA has 49.5M shares outstanding. The number of shares has increased by 81.39% in one year.
| Shares Outstanding | 49.5M |
| Shares Change (YoY) | 81.39% |
| Shares Change (QoQ) | 81.39% |
| Owned by Institutions (%) | 28.91% |
| Shares Floating | 38.41M |
| Failed to Deliver (FTD) Shares | 620 |
| FTD / Avg. Volume | 0.58% |
Short Selling Information
The latest short interest is 24.69K, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 24.69K |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.06% |
| Short Ratio (days to cover) | 0.15 |
Valuation Ratios
The PE ratio is -2.04 and the forward PE ratio is -3.84. MDxHealth SA's PEG ratio is 0.07.
| PE Ratio | -2.04 |
| Forward PE | -3.84 |
| PS Ratio | 0.86 |
| Forward PS | 0.4 |
| PB Ratio | 5.24 |
| P/FCF Ratio | -3.94 |
| PEG Ratio | 0.07 |
Enterprise Valuation
MDxHealth SA has an Enterprise Value (EV) of 120.97M.
| EV / Earnings | -3.18 |
| EV / Sales | 1.34 |
| EV / EBITDA | -7.25 |
| EV / EBIT | -4.89 |
| EV / FCF | -6.14 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 4.05.
| Current Ratio | 1.57 |
| Quick Ratio | 1.48 |
| Debt / Equity | 4.05 |
| Total Debt / Capitalization | 80.19 |
| Cash Flow / Debt | -0.31 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -2.57% and return on capital (ROIC) is -33.34%.
| Return on Equity (ROE) | -2.57% |
| Return on Assets (ROA) | -0.24% |
| Return on Capital (ROIC) | -33.34% |
| Revenue Per Employee | $300,163.33 |
| Profits Per Employee | $-126,896.67 |
| Employee Count | 300 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 9.02 |
Taxes
| Income Tax | 382K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -41.31% in the last 52 weeks. The beta is 0.38, so MDxHealth SA's price volatility has been higher than the market average.
| Beta | 0.38 |
| 52-Week Price Change | -41.31% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 38.97 |
| Average Volume (20 Days) | 106.44K |
Income Statement
In the last 12 months, MDxHealth SA had revenue of 90.05M and earned -38.07M in profits. Earnings per share was -1.16.
| Revenue | 90.05M |
| Gross Profit | 55.14M |
| Operating Income | -24.72M |
| Net Income | -38.07M |
| EBITDA | -16.68M |
| EBIT | -24.72M |
| Earnings Per Share (EPS) | -1.16 |
Balance Sheet
The company has 46.8M in cash and 60.06M in debt, giving a net cash position of -13.27M.
| Cash & Cash Equivalents | 46.8M |
| Total Debt | 60.06M |
| Net Cash | -13.27M |
| Retained Earnings | -369.51M |
| Total Assets | 157.33M |
| Working Capital | 24.23M |
Cash Flow
In the last 12 months, operating cash flow was -18.53M and capital expenditures -1.19M, giving a free cash flow of -19.72M.
| Operating Cash Flow | -18.53M |
| Capital Expenditures | -1.19M |
| Free Cash Flow | -19.72M |
| FCF Per Share | -0.6 |
Margins
Gross margin is 61.23%, with operating and profit margins of -27.45% and -42.28%.
| Gross Margin | 61.23% |
| Operating Margin | -27.45% |
| Pretax Margin | -41.85% |
| Profit Margin | -42.28% |
| EBITDA Margin | -18.53% |
| EBIT Margin | -27.45% |
| FCF Margin | -21.9% |
Dividends & Yields
MDXH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -76.32% |
| FCF Yield | -26.12% |
Analyst Forecast
The average price target for MDXH is $6, which is 294.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 294.7% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 14, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -2.72 |
| Piotroski F-Score | 3 |